Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Pilot Study of Hyperpolarized 13C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers

Pilot Study of Hyperpolarized 13C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic... ORIGINAL RESEARCH PEDIATRICS Pilot Study of Hyperpolarized C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers A.W. Autry, I. Park, C. Kline, H.-Y. Chen, J.W. Gordon, S. Raber, C. Hoffman, Y. Kim, K. Okamoto, D.B. Vigneron, J.M. Lupo, M. Prados, Y. Li, D. Xu, and S. Mueller ABSTRACT BACKGROUND AND PURPOSE: Pediatric CNS tumors commonly present challenges for radiographic interpretation on conventional MR imaging. This study sought to investigate the safety and tolerability of hyperpolarized carbon-13 (HP- C) metabolic imaging in pediatric patients with brain tumors. MATERIALS AND METHODS: Pediatric patients 3 to 18 years of age who were previously diagnosed with a brain tumor and could undergo MR imaging without sedation were eligible to enroll in this safety study of HP [1- C]pyruvate. Participants received a one- 13 13 time injection of HP [1- C]pyruvate and were imaged using dynamic HP- C MR imaging. We assessed 2 dose levels: 0.34 mL/kg and the highest tolerated adult dose of 0.43 mL/kg. Participants were monitored throughout imaging and for 60 minutes postinjection, including pre- and postinjection electrocardiograms and vital sign measurements. RESULTS: Between February 2017 and July 2019, ten participants (9 males; median age, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Neuroradiology American Journal of Neuroradiology

Pilot Study of Hyperpolarized 13C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers

Download PDF
7 pages

Loading next page...
 
/lp/american-journal-of-neuroradiology/pilot-study-of-hyperpolarized-13c-metabolic-imaging-in-pediatric-DMi6grMmYa
Publisher
American Journal of Neuroradiology
Copyright
© 2021 by American Journal of Neuroradiology
ISSN
0195-6108
eISSN
1936-959X
DOI
10.3174/ajnr.A6937
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL RESEARCH PEDIATRICS Pilot Study of Hyperpolarized C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers A.W. Autry, I. Park, C. Kline, H.-Y. Chen, J.W. Gordon, S. Raber, C. Hoffman, Y. Kim, K. Okamoto, D.B. Vigneron, J.M. Lupo, M. Prados, Y. Li, D. Xu, and S. Mueller ABSTRACT BACKGROUND AND PURPOSE: Pediatric CNS tumors commonly present challenges for radiographic interpretation on conventional MR imaging. This study sought to investigate the safety and tolerability of hyperpolarized carbon-13 (HP- C) metabolic imaging in pediatric patients with brain tumors. MATERIALS AND METHODS: Pediatric patients 3 to 18 years of age who were previously diagnosed with a brain tumor and could undergo MR imaging without sedation were eligible to enroll in this safety study of HP [1- C]pyruvate. Participants received a one- 13 13 time injection of HP [1- C]pyruvate and were imaged using dynamic HP- C MR imaging. We assessed 2 dose levels: 0.34 mL/kg and the highest tolerated adult dose of 0.43 mL/kg. Participants were monitored throughout imaging and for 60 minutes postinjection, including pre- and postinjection electrocardiograms and vital sign measurements. RESULTS: Between February 2017 and July 2019, ten participants (9 males; median age,

Journal

American Journal of Neuroradiology – American Journal of Neuroradiology

Published: Jan 1, 2021

References

  • CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016
    QT. Ostrom, C. Gino, H. Gittlem
  • Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children’s Oncology Group
    KJ. Cohen, RL. Heideman, T. Zhou
  • Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR
    JH. Ardenkjaer-Larsen, B. Fridlund, A. Gram
  • Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies
    I. Park, PEZ. Larson, JW. Gordon
  • Abstract 3755: Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214
    VZ. Miloushev, KL. Granlund, R. Boltyanskiy
  • Quantifying normal human brain metabolism using hyperpolarized [1-13C]pyruvate and magnetic resonance imaging
    JT. Grist, MA. McLean, F. Riemer
  • Lactate topography of the human brain using hyperpolarized 13C-MRI
    CY. Lee, H. Soliman, BJ. Geraghty
  • Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma
    AW. Autry, JW. Gordon, HY. Chen
  • Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.
    YL. Lunt, MG. Vander Heiden
  • Oxidative Phosphorylation at the fin de siè
  • On respiratory impairment in cancer cells.
  • Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.
    PS. Ward, CB. Thompson
  • Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate
    SJ. Nelson, J. Kurhanewicz, DB. Vigneron
  • Measuring tumor metabolism in pediatric diffuse intrinsic pontine glioma using hyperpolarized carbon-13 MR metabolic imaging
    AW. Autry, R. Hashimuza, CD. James
  • Hyperpolarized carbon-13 metabolic imaging of pediatric patients with brain tumors: initial experience
  • Diffuse intrinsic pontine glioma: poised for progress
  • HDAC inhibition in glioblastoma monitored by hyperpolarized 13C MRSI
    M. Radoul, C. Najac, P. Viswanath
  • Comparison between 8- and 32-channel phased-array receive coils for in vivo hyperpolarized 13 C imaging of the human brain
    AW. Autry, JW. Gordon, L. Carvajal
  • Translation of carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients
    JW. Gordon, HY. Chen, AW. Autry
  • Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI.
    PE. Larson, R. Bok, AB. Kerr
  • Hyperpolarized 13C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco
    JC. Crane, JW. Gordon, HY. Chen
  • Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized 13C MRSI
    HY. Chen, AW. Autry, JR. Brender
  • Age‐related changes of normal cerebral and cardiac blood flow in children and adults aged 7 months to 61 years
    C. Wu, AR. Honarmand, S. Schnell
  • Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
    V. Miranda-Goncalves, M. Honavar, C. Pinheiro
  • A variable resolution approach for improved acquisition of hyperpolarized 13C metabolic MRI
    JW. Gordon, AW. Autry, S. Tang
  • Effects of isoflurane anesthesia on hyperpolarized 13C metabolic measurements in rat brain
    S. Josan, R. Hurd, K. Billingsley